Consulting

Certara's scientific consultants support strategic drug development decisions and submission-ready analyses.

Our Practice
Home > Consulting > Our Practice > Consulting Leadership Team

Why Certara: What Makes Us Unique?

 

  • We are 75+ PhD/PharmD scientists in the disciplines of clinical pharmacology, biostatistics, clinical medicine, strategic decision-making and regulatory strategy. We serve all major drug development geographies, with scientists and business representatives in North America, Europe and the Pacific Rim.
  • We have unparalleled experience across all development phases and in all major therapeutic areas, spanning 80+ disease indications and 130 drug classes. We collaborate with clients on more than 200 client projects annually.

 

Our Consulting Leadership

 

René Bruno, PhD

Managing Director, PCS Europe

René Bruno obtained a PhD in Pharmacokinetics at the University of Marseilles in 1981. As Associate Professor in the Department of Pharmacokinetics, Read more

  

Duncan Edwards, Ph.D.

Sr. Scientific Advisor and Systems Architect

Dr. Edwards has been with Certara since 2007. He has a multidisciplinary experience spanning drug discovery, drug development and... Read more

Iain Gardner, Ph.D.

Sr. Scientfic Advisor & Head of Translational Science

Dr. Gardner has been at Certara since 2011. He leads the science team that is responsible for further developments of the population based... Read more

  

Christine Garnett, Pharm.D.

Vice President, Lead Scientist

Dr. Garnett joined Certara in 2012 after serving seven years in the Division of Pharmacometrics at the US Food and Drug Administration... Read more

Masoud Jamei, Ph.D.

Sr. Scientific Advisor, Head of Modeling & Simulation

Dr. Jamei joined Certara in 2003 and leads a team of scientists working on different aspects of model-based drug development including... Read more

  

JF Marier, Ph.D.

Vice President and Lead Scientist 

Dr. Marier has directed PK/PD analyses, reporting, and modeling and simulation projects for hundreds of studies in early and late clinical research. Read more

  

Henri Merdjan, Pharm.D.

Sr. Director

Dr. Merdjan joined Certara in 2010 after 25 years of new drug development in the industry, working successively for Sandoz, Servier France, and Servier UK...  Read more

  

William Poland, Ph.D.

Vice President and Lead Scientist

Dr. Poland has provided pharmaceutical companies guidance in drug development decisions through scientific and decision-analytic... Read more

Mark Reimer, Ph.D.

Vice President, Operations

Dr. Reimer leads a highly skilled team of clinical pharmacologists, pharmacometricians, biostatisticians, and medical writers who are... Read more

  

Amin Rostami, Pharm.D., Ph.D

Vice President of R&D

Dr. Rostami leads a team of scientists working on extrapolation of in vitro data on drug metabolism to predict... Read more

Karen Rowland Yeo, Ph.D.

Sr. Scientific Advisor and Principal Consultant

Since 2002, Dr. Rowland Yeo has supervised a team of senior scientists who have been involved in projects relating to the extrapolation of... Read more

  

Geoff Tucker, Ph.D.

Vice President, Translational Science

Dr. Tucker graduated in pharmacy (1964) with a Ph.D. (1967) from the University of London (Chelsea College), and has an Honorary Doctorate... Read more

Daniel Weiner, Ph.D.

Sr. Vice President, General Manager

Dr. Weiner has extensive drug development experience and has served as an expert consultant to the U.S. Food and Drug Administration (FDA). Read more

    

 

Resource Library

Search Our Archives